These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30864528)

  • 1. Investigation of the Roles of New Antiepileptic Drugs and Serum BDNF Levels in Efficacy and Safety Monitoring and Quality of Life: A Clinical Research.
    Demir M; Akarsu EO; Dede HO; Bebek N; Yıldız SO; Baykan B; Akkan AG
    Curr Clin Pharmacol; 2020; 15(1):49-63. PubMed ID: 30864528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
    Sarangi SC; Kaur N; Tripathi M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antiepileptic drug withdrawal status related to quality of life in seizure-free adult patients with epilepsy?
    Zou X; Hong Z; Chen J; Zhou D
    Epilepsy Behav; 2014 Feb; 31():129-35. PubMed ID: 24407247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study.
    Chen Y; Wang Q; Xu Y; Wu D; Xu L; Zhu G; Wu X
    Front Neurol; 2022; 13():855498. PubMed ID: 35756921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
    Aícua-Rapún I; André P; Rossetti AO; Ryvlin P; Hottinger AF; Decosterd LA; Buclin T; Novy J
    Ann Neurol; 2020 Jan; 87(1):22-29. PubMed ID: 31714640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability.
    Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C
    Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: Online survey of patients with epilepsy in Australia.
    Welton JM; Walker C; Riney K; Ng A; Todd L; D'Souza WJ
    Epilepsy Behav; 2020 Mar; 104(Pt A):106856. PubMed ID: 31954268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life among epileptic patients in Qassim Region, KSA.
    Altwijri RM; Aljohani MS; Alshammari HK
    Neurosciences (Riyadh); 2021 Jan; 26(1):56-61. PubMed ID: 33530044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure reduction and quality of life improvements in people with epilepsy.
    Birbeck GL; Hays RD; Cui X; Vickrey BG
    Epilepsia; 2002 May; 43(5):535-8. PubMed ID: 12027916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative retention rates and long-term tolerability of new antiepileptic drugs.
    Chung S; Wang N; Hank N
    Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.